CoChat

Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

Open access
Braffett, Barbara H., Gubitosi-Klug, Rose A., Albers, James W., Feldman, Eva L., Martin, Catherine L., White, Neil H., Orchard, Trevor J., Lopes-Virella, Maria, Lachin, John M., Pop-Busui, Rodica, the DCCT/EDIC Research Group · 2020 · Diabetes

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the risk of developing diabetic peripheral neuropathy (DPN) and cardiovascular autonomic neuropathy (CAN). We evaluated multiple risk factors and phenotypes associated with DPN and CAN in this large, well-characterized cohort of participants with type 1 diabetes, followed for >23 years. DPN was defined by symptoms, signs, and nerve conduction study abnormalities in ≥2 nerves; CAN was assessed using standardized cardiovascular reflex tests. Generalized estimating equation models assessed the association of DPN and CAN with individual risk factors measured repeatedly. During DCCT/EDIC, 33% of participants developed DPN and 44% CAN. Higher mean HbA1c was the most significant risk factor for DPN, followed by older age, longer duration, greater height, macroalbuminuria, higher mean pulse rate, β-blocker use, and sustained albuminuria. The most significant risk factor for CAN was older age, followed by higher mean HbA1c, sustained albuminuria, longer duration of type 1 diabetes, higher mean pulse rate, higher mean systolic blood pressure, β-blocker use, estimated glomerular filtration rate <60 mL/min/1.73 m2, higher most recent pulse rate, and cigarette smoking. These findings identify risk factors and phenotypes of participants with diabetic neuropathy that can be used in the design of new interventional trials and for personalized approaches to neuropathy prevention.

Overview

Integrity signals

Registry

Crossref · 10.2337/db19-1046

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. International Diabetes Federation. IDF Diabetes Atlas, 9th edition [Internet], 2019. Available from https://diabetesatlas.org

Cited by

See all 221

Metadata

Authors
Braffett, B. H., Gubitosi-Klug, R. A., Albers, J. W., Feldman, E. L., Martin, C. L., White, N. H., Orchard, T. J., Lopes-Virella, M., Lachin, J. M., Pop-Busui, R., & the DCCT/EDIC Research Group
Affiliations
  • George Washington University (US)
  • Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH
  • University of Michigan (US)
  • Washington University in St. Louis (US)
  • University of Pittsburgh (US)
  • Medical University of South Carolina (US)
  • University of Michigan Medical School, Ann Arbor, MI
Corresponding author
Braffett, Barbara H.
Venue
Diabetes
Published
2020-02-12
Volume
69
Issue
5
Pages
1000-1010
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W3006227931
Cited by
221
References
40
Citations by year
2026: 26 · 2025: 41 · 2024: 45 · 2023: 31 · 2022: 40 · 2021: 24 · 2020: 14
FWCI
20.55
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5u01dk094157-13, UL1TR002345)
  • National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK092926, P30DK020572, P30DK017047)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
  • Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
Keywords
diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, risk factors, tight glycemic control, HbA1c, albuminuria, macroalbuminuria, beta-blocker use, pulse rate, cigarette smoking, neuropathy prevention, DCCT/EDIC
MeSH terms
Adult, Autonomic Nervous System, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Female, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Cohort Studies, Multivariate Analysis, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.